In the current study, we examined the influence of intraovarian injection of autologous PRP on the levels of E2 and FSH and pregnancy outcome in women treated with PRP who had a history of infertility, hormonal abnormalities, an absence of a menstrual cycle, and premature ovarian failure in a single centre. Here, BRD2 is linked to primary ovarian failure.